$ABBV
AbbVie Inc. Stock $abbv

$abbv Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000155115220000007 Filed on February 21, 2020

Income Statement

Concept	2019 Q4	2019 Q3	2019 Q2
Revenue	$8.704B	$8.479B	$8.255B
YoY Change	4.8%	2.95%	-0.28%
Cost Of Revenue	$2.054B	$1.920B	$1.819B
YoY Change	2.44%	4.63%	-5.95%
Gross Profit	$6.698B	$6.559B	$6.436B
YoY Change	6.61%	2.47%	1.45%
Gross Profit Margin	76.95%	77.36%	77.96%
Selling, General & Admin	$1.951B	$1.657B	$1.654B
YoY Change	1.14%	-13.65%	-6.02%
% of Gross Profit	29.13%	25.26%	25.7%
Research & Development	$1.542B	$2.285B	$1.291B
YoY Change	10.54%	80.21%	-2.34%
% of Gross Profit	23.02%	34.84%	20.06%
Depreciation & Amortization	$509.0M	$114.0M	$114.0M
YoY Change	15.16%	-0.87%	-4.2%
% of Gross Profit	7.6%	1.74%	1.77%
Operating Expenses	$3.483B	$3.942B	$2.945B
YoY Change	4.78%	23.69%	-4.45%
Operating Profit	$3.215B	$2.617B	$3.400B
YoY Change	8.65%	-17.16%	23.1%
Interest Expense	-$418.0M	$480.0M	$358.0M
YoY Change	22.22%	41.59%	11.88%
% of Operating Profit	-13.0%	18.34%	10.53%
Other Income/Expense, Net	-$416.0M	$0.00	$0.00
YoY Change	-205.85%		-100.0%
Pretax Income	$3.074B	$2.001B	$807.0M
YoY Change	-229.54%	-27.53%	-59.89%
Income Tax	$273.0M	$117.0M	$66.00M
% Of Pretax Income	8.88%	5.85%	8.18%
Net Earnings	$2.801B	$1.884B	$741.0M
YoY Change	-253.4%	-31.42%	-62.63%
Net Earnings / Revenue	32.18%	22.22%	8.98%
Basic Earnings Per Share	$1.88	$1.27	$0.49
Diluted Earnings Per Share	$1.88	$1.26	$0.49
COMMON SHARES
Basic Shares Outstanding	1.479B shares	1.481B shares	1.480B shares
Diluted Shares Outstanding		1.483B shares	1.484B shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$39.92B	$10.65B	$5.416B
YoY Change	395.27%	21.21%	44.7%
Cash & Equivalents	$39.92B	$10.65B	$5.172B
Short-Term Investments	$0.00	$0.00	$244.0M
Other Short-Term Assets	$2.354B	$2.060B	$2.307B
YoY Change	24.22%	-2.55%	-15.46%
Inventory	$1.813B	$1.929B	$1.895B
Prepaid Expenses
Receivables	$5.428B	$5.529B	$5.482B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$49.52B	$20.17B	$15.10B
YoY Change	192.23%	9.21%	9.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.962B	$2.894B	$2.879B
YoY Change	2.74%	-1.9%	3.3%
Goodwill	$15.60B	$15.54B	$15.64B
YoY Change	-0.38%	-1.15%	-0.32%
Intangibles	$18.65B	$19.04B	$20.46B
YoY Change	-12.17%	-28.5%	-23.95%
Long-Term Investments	$93.00M	$131.0M	$1.473B
YoY Change	-93.45%	-91.05%	-2.13%
Other Assets	$2.288B	$1.677B	$1.589B
YoY Change	89.4%	77.84%	74.81%
Total Long-Term Assets	$39.60B	$39.28B	$42.04B
YoY Change	-6.63%	-17.66%	-12.04%
TOTAL ASSETS
Total Short-Term Assets	$49.52B	$20.17B	$15.10B
Total Long-Term Assets	$39.60B	$39.28B	$42.04B
Total Assets	$89.12B	$59.44B	$57.14B
YoY Change	50.15%	-10.16%	-7.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.452B	$12.04B	$11.15B
YoY Change	-6.08%	6.13%	4.72%
Accrued Expenses	$109.0M	$107.0M	$111.0M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$306.0M
YoY Change	-100.0%	-100.0%	-91.28%
Long-Term Debt Due	$3.753B	$5.276B	$5.335B
YoY Change	133.25%	417.76%	76.71%
Total Short-Term Liabilities	$15.59B	$17.49B	$16.94B
YoY Change	-9.59%	13.69%	-1.64%
LONG-TERM LIABILITIES
Long-Term Debt	$62.98B	$33.13B	$31.62B
YoY Change	79.92%	-9.21%	3.4%
Other Long-Term Liabilities	$17.60B	$15.99B	$16.00B
YoY Change	1246.37%	1.71%	2.94%
Total Long-Term Liabilities	$17.60B	$49.12B	$47.62B
YoY Change	1246.37%	-5.92%	3.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.59B	$17.49B	$16.94B
Total Long-Term Liabilities	$17.60B	$49.12B	$47.62B
Total Liabilities	$33.18B	$67.67B	$65.71B
YoY Change	78.92%	-2.05%	1.06%
SHAREHOLDERS EQUITY
Retained Earnings	$4.717B	$3.673B	$3.384B
YoY Change	40.05%	-45.9%	-38.42%
Common Stock	$15.19B	$15.11B	$15.03B
YoY Change	2.96%	2.94%	2.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$24.50B	$24.50B	$24.51B
YoY Change	1.64%	12.14%	17.56%
Treasury Stock Shares	302.7M shares	302.6M shares	302.7M shares
Shareholders Equity	-$8.172B	-$8.226B	-$8.566B
YoY Change
Total Liabilities & Shareholders Equity	$89.12B	$59.44B	$57.14B
YoY Change	50.15%	-10.16%	-7.3%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	$2.801B	$1.884B	$741.0M
YoY Change	-253.4%	-31.42%	-62.63%
Depreciation, Depletion And Amortization	$509.0M	$114.0M	$114.0M
YoY Change	15.16%	-0.87%	-4.2%
Cash From Operating Activities	$3.275B	$4.555B	$2.477B
YoY Change	-3.45%	0.69%	-13.57%
INVESTING ACTIVITIES
Capital Expenditures	-$163.0M	-$154.0M	-$128.0M
YoY Change	32.52%	-45.39%	12.28%
Acquisitions
YoY Change
Other Investing Activities	-$452.0M	$1.532B	-$12.00M
YoY Change	182.5%	-324.96%	-101.5%
Cash From Investing Activities	-$615.0M	$1.378B	-$140.0M
YoY Change	117.31%	-243.09%	-120.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	26.60B	-441.0M	-2.070B
YoY Change	-795.48%	-148.14%	-76.94%
NET CHANGE
Cash From Operating Activities	3.275B	4.555B	2.477B
Cash From Investing Activities	-615.0M	1.378B	-140.0M
Cash From Financing Activities	26.60B	-441.0M	-2.070B
Net Change In Cash	29.26B	5.492B	267.0M
YoY Change	-4186.87%	22.67%	-104.92%
FREE CASH FLOW
Cash From Operating Activities	$3.275B	$4.555B	$2.477B
Capital Expenditures	-$163.0M	-$154.0M	-$128.0M
Free Cash Flow	$3.438B	$4.709B	$2.605B
YoY Change	-2.19%	-2.02%	-12.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	23000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	70000000	USD
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	297686473	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	302671146	shares
CY2019	abbv	Amortization Period Of Differences Between Expected Long Term Return On Plan Assets And The Actual Return AmortizationPeriodOfDifferencesBetweenExpectedLongTermReturnOnPlanAssetsAndTheActualReturn	P5Y
CY2017	abbv	Other Comprehensive Income Loss Net Investment Hedge Tax Portion Attributableto Parent OtherComprehensiveIncomeLossNetInvestmentHedgeTaxPortionAttributabletoParent	-194000000	USD
CY2018	abbv	Other Comprehensive Income Loss Net Investment Hedge Tax Portion Attributableto Parent OtherComprehensiveIncomeLossNetInvestmentHedgeTaxPortionAttributabletoParent	40000000	USD
CY2019	abbv	Other Comprehensive Income Loss Net Investment Hedge Tax Portion Attributableto Parent OtherComprehensiveIncomeLossNetInvestmentHedgeTaxPortionAttributabletoParent	22000000	USD
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001551152
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4000000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4000000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1776510871	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1781582608	shares
CY2019Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2019Q4	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0	USD
CY2019Q4	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0	USD
CY2019Q4	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0	USD
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2017	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	-8000000	USD
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Document Annual Report DocumentAnnualReport	true
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Transition Report DocumentTransitionReport	false
CY2019	dei	Entity File Number EntityFileNumber	001-35565
CY2019	dei	Entity Registrant Name EntityRegistrantName	AbbVie Inc.
CY2019	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2019	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	32-0375147
CY2019	dei	Local Phone Number LocalPhoneNumber	932-7900
CY2019	dei	Entity Address Address Line1 EntityAddressAddressLine1	1 North Waukegan Road
CY2019	dei	Entity Address City Or Town EntityAddressCityOrTown	North Chicago
CY2019	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2019	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60064-6400
CY2018	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	0	USD
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	0	USD
CY2017	us-gaap	Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent	94000000	USD
CY2018	us-gaap	Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent	-35000000	USD
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent	323000000	USD
CY2017	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	34000000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	-18000000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	-4000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	-26000000	USD
CY2019	dei	City Area Code CityAreaCode	847
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-18000000	USD
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019Q2	dei	Entity Public Float EntityPublicFloat	106362457090	USD
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1479156683	shares
CY2019	us-gaap	Revenues Revenues	33266000000	USD
CY2018	us-gaap	Revenues Revenues	32753000000	USD
CY2017	us-gaap	Revenues Revenues	28216000000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7439000000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7718000000	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7042000000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6942000000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7399000000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6295000000	USD
CY2019	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	6407000000	USD
CY2018	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	10329000000	USD
CY2017	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	5007000000	USD
CY2019	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	385000000	USD
CY2018	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	424000000	USD
CY2017	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	327000000	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	890000000	USD
CY2018	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-500000000	USD
CY2017	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	20283000000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	26370000000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	18671000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	12983000000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	6383000000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	9545000000	USD
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1509000000	USD
CY2018	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1144000000	USD
CY2017	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1004000000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-42000000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-24000000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-348000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3006000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8426000000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-466000000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5197000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7727000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	544000000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-490000000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2418000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	7882000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	5687000000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	5309000000	USD
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.30
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.67
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.31
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.28
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.66
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.30
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1481000000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1541000000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1596000000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1484000000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1546000000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1603000000	shares
CY2019	us-gaap	Net Income Loss NetIncomeLoss	7882000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	5687000000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	5309000000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-98000000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-391000000	USD
CY2017	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	996000000	USD
CY2019	abbv	Other Comprehensive Income Loss Net Investment Hedge Gain Loss After Reclassificationand Tax Portion Attributableto Parent OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTaxPortionAttributabletoParent	74000000	USD
CY2018	abbv	Other Comprehensive Income Loss Net Investment Hedge Gain Loss After Reclassificationand Tax Portion Attributableto Parent OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTaxPortionAttributabletoParent	138000000	USD
CY2017	abbv	Other Comprehensive Income Loss Net Investment Hedge Gain Loss After Reclassificationand Tax Portion Attributableto Parent OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTaxPortionAttributabletoParent	-343000000	USD
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	1243000000	USD
CY2018	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-197000000	USD
CY2017	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	406000000	USD
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	10000000	USD
CY2018	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-10000000	USD
CY2017	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-46000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	141000000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	313000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-342000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1116000000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	247000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6766000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-141000000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5934000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5168000000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39924000000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7289000000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	772000000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5428000000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5384000000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1813000000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	1605000000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	2354000000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1895000000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	49519000000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	16945000000	USD
CY2019Q4	us-gaap	Long Term Investments LongTermInvestments	93000000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	1420000000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2962000000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2883000000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18649000000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21233000000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	15604000000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	15663000000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2288000000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1208000000	USD
CY2019Q4	us-gaap	Assets Assets	89115000000	USD
CY2018Q4	us-gaap	Assets Assets	59352000000	USD
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2018Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	3699000000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	3753000000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1609000000	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	11832000000	USD
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	11931000000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15585000000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17239000000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	62975000000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	35002000000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1130000000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1067000000	USD
CY2019Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	17597000000	USD
CY2018Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	14490000000	USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	18000000	USD
CY2018Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	18000000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	24504000000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	24108000000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	15193000000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14756000000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4717000000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3368000000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3596000000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2480000000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-8172000000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-8446000000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	89115000000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59352000000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	4636000000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	5309000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-141000000	USD
CY2017	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4221000000	USD
CY2017	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1125000000	USD
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	639000000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	5097000000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-1733000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	5687000000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	247000000	USD
CY2018	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	6045000000	USD
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	12215000000	USD
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	516000000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-8446000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	7882000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1116000000	USD
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	6533000000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	428000000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	469000000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-8172000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	7882000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	5687000000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	5309000000	USD
CY2019	us-gaap	Depreciation Depreciation	464000000	USD
CY2018	us-gaap	Depreciation Depreciation	471000000	USD
CY2017	us-gaap	Depreciation Depreciation	425000000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1553000000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1294000000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1076000000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3091000000	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	49000000	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	626000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	430000000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	421000000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	365000000	USD
CY2019	abbv	Upfront Costs Related To Collaborations UpfrontCostsRelatedToCollaborations	490000000	USD
CY2018	abbv	Upfront Costs Related To Collaborations UpfrontCostsRelatedToCollaborations	1061000000	USD
CY2017	abbv	Upfront Costs Related To Collaborations UpfrontCostsRelatedToCollaborations	470000000	USD
CY2019	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	330000000	USD
CY2018	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0	USD
CY2017	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0	USD
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1030000000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	5070000000	USD
CY2017	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	354000000	USD
CY2019	abbv	Impacts Related To U.S.Tax Reform ImpactsRelatedToU.S.TaxReform	0	USD
CY2018	abbv	Impacts Related To U.S.Tax Reform ImpactsRelatedToU.S.TaxReform	424000000	USD
CY2017	abbv	Impacts Related To U.S.Tax Reform ImpactsRelatedToU.S.TaxReform	1242000000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-43000000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-76000000	USD
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-84000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	74000000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	591000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	391000000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	231000000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	226000000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-93000000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-97000000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	499000000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	118000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1121000000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	190000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	425000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13324000000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13427000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9960000000	USD
CY2019	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1135000000	USD
CY2018	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	736000000	USD
CY2017	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	308000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	552000000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	638000000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	529000000	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	583000000	USD
CY2018	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1792000000	USD
CY2017	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2230000000	USD
CY2019	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2699000000	USD
CY2018	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2160000000	USD
CY2017	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2793000000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-167000000	USD
CY2018	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2017	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	596000000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1006000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-274000000	USD
CY2019	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	-699000000	USD
CY2018	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	299000000	USD
CY2017	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	23000000	USD
CY2019	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	0	USD
CY2018	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	3002000000	USD
CY2017	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	0	USD
CY2019	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	3000000000	USD
CY2018	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	0	USD
CY2017	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	31482000000	USD
CY2018	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	5963000000	USD
CY2019	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	1536000000	USD
CY2018	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	6035000000	USD
CY2017	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	25000000	USD
CY2019	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	424000000	USD
CY2018	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	40000000	USD
CY2017	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	USD
CY2019	us-gaap	Payments Of Dividends PaymentsOfDividends	6366000000	USD
CY2018	us-gaap	Payments Of Dividends PaymentsOfDividends	5580000000	USD
CY2017	us-gaap	Payments Of Dividends PaymentsOfDividends	4107000000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	629000000	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	12014000000	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1410000000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8000000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	254000000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	73000000	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	163000000	USD
CY2018	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	78000000	USD
CY2017	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	268000000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	35000000	USD
CY2018	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	14000000	USD
CY2017	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	21000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18708000000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14396000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5512000000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	7000000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-39000000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	29000000	USD
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	32635000000	USD
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2014000000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4203000000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7289000000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9303000000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5100000000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39924000000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7289000000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9303000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	1794000000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	1215000000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	1099000000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	1447000000	USD
CY2018	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	35000000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	1696000000	USD
CY2013Q1	abbv	Percentage Of Outstanding Common Stock Distributed PercentageOfOutstandingCommonStockDistributed	1
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;color:#444867;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) and necessarily include amounts based on estimates and assumptions by management. Actual results could differ from those amounts. Significant estimates include amounts for rebates, pension and other post-employment benefits, income taxes, litigation, valuation of goodwill and intangible assets, contingent consideration liabilities, financial instruments and inventory and accounts receivable exposures.</span></div>
CY2019	us-gaap	Advertising Expense AdvertisingExpense	1100000000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	1100000000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	846000000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	46000000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	51000000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	485000000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	473000000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	942000000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	862000000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	386000000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	270000000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1813000000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	1605000000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8188000000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8396000000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5226000000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5513000000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2962000000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2883000000	USD
CY2019	us-gaap	Depreciation Depreciation	464000000	USD
CY2018	us-gaap	Depreciation Depreciation	471000000	USD
CY2017	us-gaap	Depreciation Depreciation	425000000	USD
CY2019	us-gaap	Interest Expense InterestExpense	1784000000	USD
CY2018	us-gaap	Interest Expense InterestExpense	1348000000	USD
CY2017	us-gaap	Interest Expense InterestExpense	1150000000	USD
CY2019	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	275000000	USD
CY2018	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	204000000	USD
CY2017	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	146000000	USD
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1509000000	USD
CY2018	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1144000000	USD
CY2017	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1004000000	USD
CY2019Q4	abbv	Accrued Sales Rebates AccruedSalesRebates	4484000000	USD
CY2018Q4	abbv	Accrued Sales Rebates AccruedSalesRebates	3939000000	USD
CY2019Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1771000000	USD
CY2018Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1607000000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1452000000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1546000000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	830000000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	787000000	USD
CY2019Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	324000000	USD
CY2018Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	304000000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2971000000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3748000000	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	11832000000	USD
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	11931000000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	7201000000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4306000000	USD
CY2019Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	3453000000	USD
CY2018Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	4311000000	USD
CY2019Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	2949000000	USD
CY2018Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	1840000000	USD
CY2019Q4	abbv	Unrecognized Tax Benefits Liabilities UnrecognizedTaxBenefitsLiabilities	2772000000	USD
CY2018Q4	abbv	Unrecognized Tax Benefits Liabilities UnrecognizedTaxBenefitsLiabilities	2726000000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1222000000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1307000000	USD
CY2019Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	17597000000	USD
CY2018Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	14490000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	7882000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	5687000000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	5309000000	USD
CY2019	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	40000000	USD
CY2018	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	30000000	USD
CY2017	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	26000000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7842000000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5657000000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5283000000	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1481000000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1541000000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1596000000	shares
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.30
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.67
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.31
CY2019	us-gaap	Net Income Loss NetIncomeLoss	7882000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	5687000000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	5309000000	USD
CY2019	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	40000000	USD
CY2018	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	30000000	USD
CY2017	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	26000000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7842000000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5657000000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5283000000	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1481000000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1541000000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1596000000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3000000	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5000000	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	7000000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1484000000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1546000000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1603000000	shares
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.28
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.66
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.30
CY2019Q2	us-gaap	Share Price SharePrice	78.45
CY2019	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1100000000	USD
CY2018	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	736000000	USD
CY2017	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	308000000	USD
CY2019	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	385000000	USD
CY2018	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	424000000	USD
CY2017	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	327000000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	15785000000	USD
CY2018	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-122000000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	15663000000	USD
CY2019	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-59000000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	15604000000	USD
CY2019Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	27345000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8696000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18649000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23737000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7424000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16313000000	USD
CY2019Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	0	USD
CY2019Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	0	USD
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4920000000	USD
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4920000000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	27345000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8696000000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18649000000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	28657000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7424000000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21233000000	USD
CY2017	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1600000000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1100000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1800000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2000000000.0	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2300000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2400000000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2500000000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2017	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	354000000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	87000000	USD
CY2017	us-gaap	Restructuring Charges RestructuringCharges	86000000	USD
CY2017	abbv	Restructuring Reserve Period Cash Settled And Other Adjustments RestructuringReservePeriodCashSettledAndOtherAdjustments	87000000	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	86000000	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	59000000	USD
CY2018	abbv	Restructuring Reserve Period Cash Settled And Other Adjustments RestructuringReservePeriodCashSettledAndOtherAdjustments	46000000	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	99000000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	219000000	USD
CY2019	abbv	Restructuring Reserve Period Cash Settled And Other Adjustments RestructuringReservePeriodCashSettledAndOtherAdjustments	178000000	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	140000000	USD
CY2019Q4	abbv	Lease Rightof Use Asset LeaseRightofUseAsset	367000000	USD
CY2019Q4	abbv	Lease Liability LeaseLiability	387000000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	124000000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	34000000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	62000000	USD
CY2019	us-gaap	Lease Cost LeaseCost	220000000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	161000000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	169000000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2019Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039
CY2019Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.039
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	125000000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	26000000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	119000000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	10000000	USD
CY2019Q4	abbv	Lease Liability Payments Remainderof Fiscal Year LeaseLiabilityPaymentsRemainderofFiscalYear	129000000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	104000000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	9000000	USD
CY2019Q4	abbv	Lease Liability Payments Due Year Two LeaseLiabilityPaymentsDueYearTwo	113000000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	59000000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	8000000	USD
CY2019Q4	abbv	Lease Liability Payments Due Year Three LeaseLiabilityPaymentsDueYearThree	67000000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	38000000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1000000	USD
CY2019Q4	abbv	Lease Liability Payments Due Year Four LeaseLiabilityPaymentsDueYearFour	39000000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	22000000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2019Q4	abbv	Lease Liability Payments Due Year Five LeaseLiabilityPaymentsDueYearFive	22000000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	58000000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2019Q4	abbv	Lease Liability Payments Dueafter Year Five LeaseLiabilityPaymentsDueafterYearFive	58000000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	400000000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	28000000	USD
CY2019Q4	abbv	Lease Liability Payments Due LeaseLiabilityPaymentsDue	428000000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	40000000	USD
CY2019Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	1000000	USD
CY2019Q4	abbv	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	41000000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	360000000	USD
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	27000000	USD
CY2019Q4	abbv	Lease Liability LeaseLiability	387000000	USD
CY2019Q4	abbv	Lessee Lease Lease Notyet Commenced Contractual Minimum Payments LesseeLeaseLeaseNotyetCommencedContractualMinimumPayments	350000000	USD
CY2019	abbv	Lessee Lease Lease Notyet Commenced Termof Contract LesseeLeaseLeaseNotyetCommencedTermofContract	P11Y
CY2019Q4	abbv	Long Term Debt And Capital Lease Obligations Fair Value Hedges LongTermDebtAndCapitalLeaseObligationsFairValueHedges	48000000	USD
CY2018Q4	abbv	Long Term Debt And Capital Lease Obligations Fair Value Hedges LongTermDebtAndCapitalLeaseObligationsFairValueHedges	466000000	USD
CY2019Q4	abbv	Long Term Debt And Capital Lease Obligations Debt Instrument Unamortized Discounts LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedDiscounts	161000000	USD
CY2018Q4	abbv	Long Term Debt And Capital Lease Obligations Debt Instrument Unamortized Discounts LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedDiscounts	120000000	USD
CY2019Q4	abbv	Long Term Debt And Capital Lease Obligations Debt Instrument Unamortized Financing Costs LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedFinancingCosts	323000000	USD
CY2018Q4	abbv	Long Term Debt And Capital Lease Obligations Debt Instrument Unamortized Financing Costs LongTermDebtAndCapitalLeaseObligationsDebtInstrumentUnamortizedFinancingCosts	163000000	USD
CY2019Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	66728000000	USD
CY2018Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	36611000000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	3753000000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1609000000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	62975000000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	35002000000	USD
CY2019Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	4000000000.0	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3750000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6300000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7850000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2250000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	5375000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	41708000000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	67233000000	USD
CY2019Q4	abbv	Long Term Debt And Capital Lease Obligations Fair Value Hedges Unamortized Bond Discounts Deferred Financing Costs And Finance Lease Obligations LongTermDebtAndCapitalLeaseObligationsFairValueHedgesUnamortizedBondDiscountsDeferredFinancingCostsAndFinanceLeaseObligations	505000000	USD
CY2019Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	66728000000	USD
CY2019Q4	us-gaap	Number Of Credit Risk Derivatives Held NumberOfCreditRiskDerivativesHeld	0	company
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	53000000	USD
CY2018Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	132000000	USD
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	132000000	USD
CY2018Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	492000000	USD
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4483000000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4534000000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4213000000	USD
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3091000000	USD
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-49000000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-626000000	USD
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	234000000	USD
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	100000000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	305000000	USD
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7340000000	USD
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4483000000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4534000000	USD
CY2019Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	66000000	USD
CY2018Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	84000000	USD
CY2019	abbv	Available For Sale Securities Maturity Period Of Securities Maximum AvailableForSaleSecuritiesMaturityPeriodOfSecuritiesMaximum	P5Y
CY2018Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	1546000000	USD
CY2018Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000000	USD
CY2018Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	11000000	USD
CY2018Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1536000000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities	0	USD
CY2017	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	90000000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	7600000000	USD
CY2018Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	6000000000.0	USD
CY2019Q4	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Accumulated Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation	5800000000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Projected Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation	6700000000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets	4800000000	USD
CY2019	abbv	Defined Benefit Plan Ultimate Health Care Cost Trend Rate Assumed To Decrease DefinedBenefitPlanUltimateHealthCareCostTrendRateAssumedToDecrease	0.045
CY2019Q4	us-gaap	Defined Benefit Plan Ultimate Health Care Cost Trend Rate1 DefinedBenefitPlanUltimateHealthCareCostTrendRate1	0.045
CY2019	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Increase On Service And Interest Cost Components DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents	13000000	USD
CY2019	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Decrease On Service And Interest Cost Components1 DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1	10000000	USD
CY2019	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Increase On Accumulated Postretirement Benefit Obligation DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation	244000000	USD
CY2019	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Decrease On Accumulated Postretirement Benefit Obligation1 DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1	186000000	USD
CY2019Q4	abbv	Defined Benefit Plan Fair Valueof Plan Assets Net Asset Value DefinedBenefitPlanFairValueofPlanAssetsNetAssetValue	4265000000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	7116000000	USD
CY2018Q4	abbv	Defined Benefit Plan Fair Valueof Plan Assets Net Asset Value DefinedBenefitPlanFairValueofPlanAssetsNetAssetValue	3278000000	USD
CY2018Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	5637000000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	100000000	shares
CY2019	abbv	Share Based Compensation Arrangement By Share Based Payment Award Retirement Eligible Age ShareBasedCompensationArrangementByShareBasedPaymentAwardRetirementEligibleAge	P55Y
CY2019	abbv	Share Based Compensation Arrangement By Share Based Payment Award Retirement Eligible Employees Number Of Years Of Services ShareBasedCompensationArrangementByShareBasedPaymentAwardRetirementEligibleEmployeesNumberOfYearsOfServices	P10Y
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	430000000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	421000000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	365000000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	80000000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	73000000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	73000000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	350000000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	348000000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	292000000	USD
CY2019	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	15000000	USD
CY2018	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	78000000	USD
CY2017	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	71000000	USD
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	4.39
CY2018	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.95
CY2017	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.63
CY2019Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.18
CY2018Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.07
CY2017Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.71
CY2019Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.07
CY2018Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.96
CY2017Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.64
CY2019Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.07
CY2018Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.96
CY2017Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.64
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.07
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.96
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.64
CY2019Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4000000000.0	USD
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax	0	USD
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2784000000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4274000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2678000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	11210000000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	9471000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	10405000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8426000000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5197000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7727000000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	102000000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	593000000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6204000000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	320000000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	434000000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	376000000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	422000000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1027000000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6580000000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-137000000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1497000000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4898000000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	259000000	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-20000000	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	736000000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	122000000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1517000000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4162000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	544000000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-490000000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2418000000	USD
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.084
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.287
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.122
CY2019	abbv	Effective Income Tax Rate Reconciliation Us Tax Credits EffectiveIncomeTaxRateReconciliationUsTaxCredits	0.033
CY2018	abbv	Effective Income Tax Rate Reconciliation Us Tax Credits EffectiveIncomeTaxRateReconciliationUsTaxCredits	0.073
CY2017	abbv	Effective Income Tax Rate Reconciliation Us Tax Credits EffectiveIncomeTaxRateReconciliationUsTaxCredits	0.040
CY2019	abbv	Effective Income Tax Rate Reconciliation Impacts Relatedto U.S.Tax Reform EffectiveIncomeTaxRateReconciliationImpactsRelatedtoU.S.TaxReform	-0.016
CY2018	abbv	Effective Income Tax Rate Reconciliation Impacts Relatedto U.S.Tax Reform EffectiveIncomeTaxRateReconciliationImpactsRelatedtoU.S.TaxReform	0.082
CY2017	abbv	Effective Income Tax Rate Reconciliation Impacts Relatedto U.S.Tax Reform EffectiveIncomeTaxRateReconciliationImpactsRelatedtoU.S.TaxReform	0.120
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.002
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.015
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.009
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.047
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.025
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.012
CY2019	abbv	Deferredtaxremeasurementsduetochangeintaxrate Deferredtaxremeasurementsduetochangeintaxrate	0.031
CY2018	abbv	Deferredtaxremeasurementsduetochangeintaxrate Deferredtaxremeasurementsduetochangeintaxrate	0
CY2017	abbv	Deferredtaxremeasurementsduetochangeintaxrate Deferredtaxremeasurementsduetochangeintaxrate	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.006
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.014
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.026
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.065
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.094
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.313
CY2019	abbv	Income Tax Examination Liability Refund Adjustmentfrom Settlementwith Taxing Authority Recognizedin Income Tax Expense IncomeTaxExaminationLiabilityRefundAdjustmentfromSettlementwithTaxingAuthorityRecognizedinIncomeTaxExpense	-400000000	USD
CY2018	abbv	Income Tax Examination Liability Refund Adjustmentfrom Settlementwith Taxing Authority Recognizedin Income Tax Expense IncomeTaxExaminationLiabilityRefundAdjustmentfromSettlementwithTaxingAuthorityRecognizedinIncomeTaxExpense	-131000000	USD
CY2017	abbv	Income Tax Examination Liability Refund Adjustmentfrom Settlementwith Taxing Authority Recognizedin Income Tax Expense IncomeTaxExaminationLiabilityRefundAdjustmentfromSettlementwithTaxingAuthorityRecognizedinIncomeTaxExpense	-91000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	810000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	529000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	371000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	371000000	USD
CY2019Q4	abbv	Deferred Tax Assets Chargebacks And Rebates DeferredTaxAssetsChargebacksAndRebates	477000000	USD
CY2018Q4	abbv	Deferred Tax Assets Chargebacks And Rebates DeferredTaxAssetsChargebacksAndRebates	417000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	615000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	867000000	USD
CY2019Q4	abbv	Deferred Tax Assets Operating Loss And Other Tax Credit Carryforwards DeferredTaxAssetsOperatingLossAndOtherTaxCreditCarryforwards	838000000	USD
CY2018Q4	abbv	Deferred Tax Assets Operating Loss And Other Tax Credit Carryforwards DeferredTaxAssetsOperatingLossAndOtherTaxCreditCarryforwards	228000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	406000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	353000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3517000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2765000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	731000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	103000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2786000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2662000000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2712000000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2940000000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	249000000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	211000000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	440000000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	250000000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3401000000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3401000000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	615000000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	739000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	731000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	103000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2852000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2701000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1168000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	113000000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	163000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1768000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	499000000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	110000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	16000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	21000000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	36000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	749000000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	79000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	233000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	33000000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	7000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	16000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2661000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2852000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2701000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2400000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2700000000	USD
CY2019Q4	abbv	Reimbursement Receivable For Unrecognized Tax Benefit And Related Interest And Penalties ReimbursementReceivableForUnrecognizedTaxBenefitAndRelatedInterestAndPenalties	83000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	51000000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	73000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	24000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	191000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	190000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	120000000	USD
CY2019Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	54000000	USD
CY2019Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	290000000	USD
CY2018Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	350000000	USD
CY2014Q4	abbv	Putative Class Action Lawsuit Individual Number PutativeClassActionLawsuitIndividualNumber	5	individual
CY2019	abbv	Percentageof Claims Subjectto Settlement Agreements PercentageofClaimsSubjecttoSettlementAgreements	0.80
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2019	abbv	Number Of Principal Us Customers NumberOfPrincipalUSCustomers	3	wholesaler
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33266000000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32753000000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28216000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33266000000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32753000000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28216000000	USD
CY2019Q4	us-gaap	Noncurrent Assets NoncurrentAssets	2962000000	USD
CY2018Q4	us-gaap	Noncurrent Assets NoncurrentAssets	2883000000	USD
CY2019Q1	us-gaap	Revenues Revenues	7828000000	USD
CY2018Q1	us-gaap	Revenues Revenues	7934000000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	6134000000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	6007000000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	2456000000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	2783000000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.65
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.74
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.65
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.74
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.07
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.96
CY2019Q2	us-gaap	Revenues Revenues	8255000000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	1983000000	USD
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2018Q2	us-gaap	Revenues Revenues	8278000000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	6436000000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	6344000000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	741000000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	6401000000	USD
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.26
CY2019Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.07
CY2018Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.96
CY2019Q3	us-gaap	Revenues Revenues	8479000000	USD
CY2018Q3	us-gaap	Revenues Revenues	8236000000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	6559000000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	1884000000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	2747000000	USD
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.27
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.81
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.26
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.81
CY2019Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.07
CY2018Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.96
CY2019Q4	us-gaap	Revenues Revenues	8704000000	USD
CY2018Q4	us-gaap	Revenues Revenues	8305000000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	6698000000	USD
CY2018Q4	us-gaap	Gross Profit GrossProfit	6283000000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	2801000000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-1826000000	USD
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.88
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.23
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.88
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.23
CY2019Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.18
CY2018Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.07
CY2019Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	171000000	USD
CY2019Q1	abbv	Significant Restructuring Charges After Tax SignificantRestructuringChargesAfterTax	133000000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-148000000	USD
CY2018Q1	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	100000000	USD
CY2019Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2300000000	USD
CY2018Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	485000000	USD
CY2019Q3	abbv	Impairmentof Intangible Assets Indefinitelived Excluding Goodwill After Tax ImpairmentofIntangibleAssetsIndefinitelivedExcludingGoodwillAfterTax	912000000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	182000000	USD
CY2018Q3	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	176000000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	95000000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	438000000	USD
CY2019Q4	abbv	Legal Settlement Income After Tax LegalSettlementIncomeAfterTax	435000000	USD
CY2018Q4	abbv	Impairmentof Intangible Assets Indefinitelived Excluding Goodwill After Tax ImpairmentofIntangibleAssetsIndefinitelivedExcludingGoodwillAfterTax	4500000000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-375000000	USD

Files In Submission

Name	View Source	Status
0001551152-20-000007-index-headers.html	Edgar Link	pending
0001551152-20-000007-index.html	Edgar Link	pending
0001551152-20-000007.txt	Edgar Link	pending
0001551152-20-000007-xbrl.zip	Edgar Link	pending
abbv-20191231.xsd	Edgar Link	pending
abbv-20191231x10k.htm	Edgar Link	pending
abbv-20191231x10k_htm.xml	Edgar Link	completed
abbv-20191231xex21.htm	Edgar Link	pending
abbv-20191231xex23.htm	Edgar Link	pending
abbv-20191231xex311.htm	Edgar Link	pending
abbv-20191231xex312.htm	Edgar Link	pending
abbv-20191231xex321.htm	Edgar Link	pending
abbv-20191231xex322.htm	Edgar Link	pending
abbv-20191231xex41.htm	Edgar Link	pending
abbv-20191231_cal.xml	Edgar Link	unprocessable
abbv-20191231_def.xml	Edgar Link	unprocessable
abbv-20191231_lab.xml	Edgar Link	unprocessable
abbv-20191231_pre.xml	Edgar Link	unprocessable
abbvieimage1a31.jpg	Edgar Link	pending
abbvieimage2a14.gif	Edgar Link	pending
abbvieperformancegraph2019.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ABBV
AbbVie Inc. Stock $abbv

2019 Q4 Form 10-K Financial Statement

#000155115220000007 Filed on February 21, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ABBV AbbVie Inc. Stock $abbv

2019 Q4 Form 10-K Financial Statement

#000155115220000007 Filed on February 21, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ABBV
AbbVie Inc. Stock $abbv